These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7191300)

  • 21. [On the diuretic and saluretic activity of p-hydroxytriamterene and methoxytriamterene (author's transl)].
    Vollmer G; Mutschler E; Völger KD
    Arzneimittelforschung; 1981; 31(3):529-30. PubMed ID: 7194678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of triamterene after i.v. administration to man: determination of bioavailability.
    Gilfrich HJ; Kremer G; Möhrke W; Mutschler E; Völger KD
    Eur J Clin Pharmacol; 1983; 25(2):237-41. PubMed ID: 6628507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form.
    Jantratid E; De Maio V; Ronda E; Mattavelli V; Vertzoni M; Dressman JB
    Eur J Pharm Sci; 2009 Jun; 37(3-4):434-41. PubMed ID: 19491035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma and urinary levels of triamterene and certain metabolites after oral administration to man.
    Gundert-Remy U; von Kenne D; Weber E; Geissler HE; Grebian B; Mutschler E
    Eur J Clin Pharmacol; 1979 Aug; 16(1):39-44. PubMed ID: 499298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on formulation and bioavailability of benorilate tablets].
    Chen J; Tu XD
    Yao Xue Xue Bao; 1994; 29(9):707-12. PubMed ID: 7900541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro-in vivo correlation, a time scaling problem? Evaluation of mean times.
    Brockmeier D
    Arzneimittelforschung; 1984; 34(11):1604-7. PubMed ID: 6543138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed elimination of triamterene and its active metabolite in chronic renal failure.
    Knauf H; Möhrke W; Mutschler E
    Eur J Clin Pharmacol; 1983; 24(4):453-6. PubMed ID: 6861860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates.
    Khan MK; Khan MF; Khan H; Mustafa G
    Pak J Pharm Sci; 2009 Jul; 22(3):329-34. PubMed ID: 19553184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro dissolution kinetic study of theophylline from hydrophilic and hydrophobic matrices.
    Maswadeh HM; Semreen MH; Abdulhalim AA
    Acta Pol Pharm; 2006; 63(1):63-7. PubMed ID: 17515331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic fate and solubility of triamterene--not an explanation for triamterene nephrolithiasis.
    Sörgel F; Ettinger B; Benet LZ
    J Pharm Sci; 1986 Feb; 75(2):129-32. PubMed ID: 3958920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Release of norfenefrine from sustained-release formulations by an in vitro dissolution model. Simulation of "drug levels" by calculation using pharmacokinetical constants and comparison with in vivo course of action (author's transl)].
    Laven R; Schäfer EA
    Arzneimittelforschung; 1981; 31(2):353-6. PubMed ID: 7194653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative dissolution testing of paracetamol commercial tablet dosage forms.
    Ozkan Y; Ozalp Y; Savaşer A; Ozkan SA
    Acta Pol Pharm; 2000; 57(1):33-41. PubMed ID: 10846795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution and pharmacokinetics of triamterene in rats.
    Kau ST; Sastry BV
    J Pharm Sci; 1977 Jan; 66(1):53-6. PubMed ID: 833742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrepancy among dissolution rates of commercial tablets as a function of dissolution method. Part 5: In vitro/in vivo correlation for chlorpromazine hydrochloride tablets.
    Ammar HO; Khalil RM; Omar SM
    Pharmazie; 1993 Dec; 48(12):932-5. PubMed ID: 8115438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative in vitro dissolution studies of piroxicam suppositories using the basket, the paddle and the flow through methods].
    Horváth G; Nagy K
    Acta Pharm Hung; 1994 Jul; 64(4):135-40. PubMed ID: 7976368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation on different levels of in vitro-in vivo correlation: gemfibrozil immediate release capsule.
    Rouini MR; Ardakani YH; Mirfazaelian A; Hakemi L; Baluchestani M
    Biopharm Drug Dispos; 2008 Sep; 29(6):349-55. PubMed ID: 18615873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and pharmacodynamics of triamterene and hydrochlorothiazide and their combination in healthy volunteers.
    Möhrke W; Knauf H; Mutschler E
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):447-52. PubMed ID: 9352394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo/in vitro correlations for four differently dissolving ketorolac tablets.
    Gordon MS; Chowhan Z
    Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The true composition of kidney stones passed during triamterene therapy.
    Sörgel F; Ettinger B; Benet LZ
    J Urol; 1985 Nov; 134(5):871-3. PubMed ID: 4057369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.